A newly signed deal between the Center for Disease Control and Prevention and Group K Diagnostics will set up the federal agency and the Center City diagnostics startup to design an easy-to-use test for the Zika virus.

Over the coming months, the two organizations will work to to transform the CDC’s test tube-based assay (an analytic procedure) for the detection of the virus into a non-invasive, rapid detection test to be quickly performed by clinical staffers in areas without access to lab testing.

No financial details from the deal were disclosed, but the company said the design process will be carried out over the next three to six months.

READ FULL ARTICLE HERE